TY - JOUR
KW - buprenorphine
KW - COVID-19
KW - Medication for addiction treatment
KW - Medication for opioid use disorder
KW - Methadone
KW - telehealth
AU - P. C. Treitler
AU - C. F. Bowden
AU - J. Lloyd
AU - M. Enich
AU - A. N. Nyaku
AU - S. Crystal
A1 - 
AD - Center for Health Services Research, Institute for Health, Health Care Policy and Aging Research, Rutgers, the State University of New Jersey, 112 Paterson St. 3rd Floor, New Brunswick, NJ 08901, United States of America. Electronic address: peter.treitler@rutgers.edu.; Center for Health Services Research, Institute for Health, Health Care Policy and Aging Research, Rutgers, the State University of New Jersey, 112 Paterson St. 3rd Floor, New Brunswick, NJ 08901, United States of America.; Center for Health Services Research, Institute for Health, Health Care Policy and Aging Research, Rutgers, the State University of New Jersey, 112 Paterson St. 3rd Floor, New Brunswick, NJ 08901, United States of America.; Center for Prevention Science, School of Social Work, Rutgers, the State University of New Jersey, 390 George St., 5th Floor, New Brunswick, NJ 08901, United States of America.; Rutgers New Jersey Medical School, 185 South Orange Avenue Room I 689, Newark, NJ 07101, United States of America.; Center for Health Services Research, Institute for Health, Health Care Policy and Aging Research, Rutgers, the State University of New Jersey, 112 Paterson St. 3rd Floor, New Brunswick, NJ 08901, United States of America.
BT - Journal of substance abuse treatment
C5 - Education & Workforce; Financing & Sustainability; Healthcare Policy; HIT & Telehealth; Opioids & Substance Use
CY - United States
DO - https://doi.org/10.1016/j.jsat.2021.108514
JF - Journal of substance abuse treatment
LA - eng
M1 - Journal Article
PB - Elsevier Inc
PP - United States
PY - 2021
SN - 1873-6483; 0740-5472
SP - 108514
T1 - Perspectives of opioid use disorder treatment providers during COVID-19: Adapting to flexibilities and sustaining reforms
T2 - Journal of substance abuse treatment
TI - Perspectives of opioid use disorder treatment providers during COVID-19: Adapting to flexibilities and sustaining reforms
U1 - Education & Workforce; Financing & Sustainability; Healthcare Policy; HIT & Telehealth; Opioids & Substance Use
U2 - 34098210
U3 - https://doi.org/10.1016/j.jsat.2021.108514
VL - 132
VO - 1873-6483; 0740-5472
Y1 - 2021
Y2 - May 31
ER -